These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25893985)

  • 1. Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: A derivative of tetrandrine.
    Zhang YX; Liu XM; Wang J; Li J; Liu Y; Zhang H; Yu XW; Wei N
    Cancer Biol Ther; 2015; 16(6):965-75. PubMed ID: 25893985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and -independent manner via PUMA-Bak axis.
    Adlakha YK; Saini N
    Cell Death Dis; 2013 Mar; 4(3):e542. PubMed ID: 23492773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK- and Akt-mediated Puma expression in the apoptosis of cisplatin-resistant ovarian cancer cells.
    Zhao Z; Wang J; Tang J; Liu X; Zhong Q; Wang F; Hu W; Yuan Z; Nie C; Wei Y
    Biochem J; 2012 Jun; 444(2):291-301. PubMed ID: 22394200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer.
    Dey P; Ström A; Gustafsson JÅ
    Oncogene; 2014 Aug; 33(33):4213-25. PubMed ID: 24077289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHOP potentially co-operates with FOXO3a in neuronal cells to regulate PUMA and BIM expression in response to ER stress.
    Ghosh AP; Klocke BJ; Ballestas ME; Roth KA
    PLoS One; 2012; 7(6):e39586. PubMed ID: 22761832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.
    Zhang L; Wang H; Li W; Zhong J; Yu R; Huang X; Wang H; Tan Z; Wang J; Zhang Y
    Oncotarget; 2017 Jan; 8(2):3289-3303. PubMed ID: 27924057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The essential role of p53-up-regulated modulator of apoptosis (Puma) and its regulation by FoxO3a transcription factor in β-amyloid-induced neuron death.
    Akhter R; Sanphui P; Biswas SC
    J Biol Chem; 2014 Apr; 289(15):10812-10822. PubMed ID: 24567336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosolic and mitochondrial ROS production resulted in apoptosis induction in breast cancer cells treated with Crocin: The role of FOXO3a, PTEN and AKT signaling.
    Nasimian A; Farzaneh P; Tamanoi F; Bathaie SZ
    Biochem Pharmacol; 2020 Jul; 177():113999. PubMed ID: 32353423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ipatasertib, a novel Akt inhibitor, induces transcription factor FoxO3a and NF-κB directly regulates PUMA-dependent apoptosis.
    Sun L; Huang Y; Liu Y; Zhao Y; He X; Zhang L; Wang F; Zhang Y
    Cell Death Dis; 2018 Sep; 9(9):911. PubMed ID: 30185800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PUMA induction by FoxO3a mediates the anticancer activities of the broad-range kinase inhibitor UCN-01.
    Dudgeon C; Wang P; Sun X; Peng R; Sun Q; Yu J; Zhang L
    Mol Cancer Ther; 2010 Nov; 9(11):2893-902. PubMed ID: 20978166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myc and PI3K/AKT signaling cooperatively repress FOXO3a-dependent PUMA and GADD45a gene expression.
    Amente S; Zhang J; Lavadera ML; Lania L; Avvedimento EV; Majello B
    Nucleic Acids Res; 2011 Dec; 39(22):9498-507. PubMed ID: 21835778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18β-glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells.
    Sharma G; Kar S; Palit S; Das PK
    J Cell Physiol; 2012 May; 227(5):1923-31. PubMed ID: 21732363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells.
    Liu H; Yin J; Wang C; Gu Y; Deng M; He Z
    Anticancer Drugs; 2014 Sep; 25(8):898-907. PubMed ID: 24814195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/FoxO3a/PUMA axis in colorectal cancer.
    Yan J; Yang S; Tian H; Zhang Y; Zhao H
    Cell Death Dis; 2020 Nov; 11(11):943. PubMed ID: 33139695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation.
    Jabbour AM; Daunt CP; Green BD; Vogel S; Gordon L; Lee RS; Silke N; Pearson RB; Vandenberg CJ; Kelly PN; Nutt SL; Strasser A; Borner C; Ekert PG
    Blood; 2010 Jan; 115(2):344-52. PubMed ID: 19965665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-9 mediates Puma activation in UCN-01-induced apoptosis.
    Nie C; Luo Y; Zhao X; Luo N; Tong A; Liu X; Yuan Z; Wang C; Wei Y
    Cell Death Dis; 2014 Oct; 5(10):e1495. PubMed ID: 25356864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling.
    Yang FY; Zhang L; Zheng Y; Dong H
    Bioengineered; 2022 Jan; 13(1):1377-1387. PubMed ID: 34974801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells.
    Coloff JL; Mason EF; Altman BJ; Gerriets VA; Liu T; Nichols AN; Zhao Y; Wofford JA; Jacobs SR; Ilkayeva O; Garrison SP; Zambetti GP; Rathmell JC
    J Biol Chem; 2011 Feb; 286(7):5921-33. PubMed ID: 21159778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forkhead Box O3a requires BAF57, a subunit of chromatin remodeler SWI/SNF complex for induction of p53 up-regulated modulator of apoptosis (Puma) in a model of Parkinson's disease.
    Sanphui P; Kumar Das A; Biswas SC
    J Neurochem; 2020 Sep; 154(5):547-561. PubMed ID: 31971251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal.
    You H; Pellegrini M; Tsuchihara K; Yamamoto K; Hacker G; Erlacher M; Villunger A; Mak TW
    J Exp Med; 2006 Jul; 203(7):1657-63. PubMed ID: 16801400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.